For licensed healthcare professionals. The protocol figures below are drawn from published labeling and peer-reviewed literature for educational reference. They are not a prescription, not a recommendation, and not a substitute for the dispensing pharmacy's labeling or your own clinical judgment.
Sexual Health
PT-141
aka Bremelanotide, Vyleesi
FDA approved Not WADA-listed
Melanocortin receptor agonist FDA-approved for hypoactive sexual desire disorder in premenopausal women. SC injection on-demand.
At a glance
- Common vial size
- 10 mg
- Reference dose
- 1.75 mg
- Frequency
- PRN — max 1 dose/24 h, 8 doses/month
Reference titration protocol
500 mcg × 8 wks → 1000 mcg × 4 wks → 1500 mcg × 4 wks, once daily.
| Step | Dose | Duration | Administrations / week |
|---|---|---|---|
| 1 | 500 mcg | 4 weeks | 7× |
| 2 | 1 mg | 4 weeks | 7× |
| 3 | 1.5 mg | 4 weeks | 7× |
Reconstitution example
A 10 mg vial reconstituted with 3 mL of bacteriostatic water yields 3.333 mg/mL. Confirm the diluent and volume against the labeling that ships with the vial.
Open this configuration in the calculatorClinical notes
- Transient BP elevation — avoid in uncontrolled hypertension
Available formulations
Presentations carried across the VitaRelay pharmacy network, including 503A compounded, 503B outsourcing facility, and research & development sourcing. Pricing and state-level availability are shown to verified accounts only.
- Injectable503A
- Lyophilized PowderR&D
- Nasal Spray503A
- Pen503B
References
Pricing and ordering are for verified accounts
VitaRelay serves licensed practices, prescribers, and pharmacies. Catalog pricing, availability by state, and ordering are available after your account is verified.